Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jonathan R. Young, Shayan A. Smani, Nicholas A. Mischel, Michael D. Kritzer, Lawrence G. Appelbaum & Ashwin A. Patkar. (2020) Non-invasive brain stimulation modalities for the treatment and prevention of opioid use disorder: a systematic review of the literature. Journal of Addictive Diseases 38:2, pages 186-199.
Read now
Read now
Dakwar Elias & Herbert D. Kleber. (2017) Minding the brain: the role of pharmacotherapy in substance-use disorder treatment. Dialogues in Clinical Neuroscience 19:3, pages 289-297.
Read now
Read now
Articles from other publishers (50)
Lei Wang, Yue Qin, Xiaoshi Li, Xin Li, Yuwei Liu, Wei Li & Yarong Wang. (2023) Glymphatic-System Function Is Associated with Addiction and Relapse in Heroin Dependents Undergoing Methadone Maintenance Treatment. Brain Sciences 13:9, pages 1292.
Crossref
Crossref
Hyeri Park, Mingliang Lin, Jian Zhou, Lisa M. Eubanks, Bin Zhou & Kim D. Janda. (2023) Development of a vaccine against the synthetic opioid U-47700. Frontiers in Pharmacology 14.
Crossref
Crossref
Tao Li, Yi Wei Zeng, Feng Zhang, Xin Zhou & Yulan Ren. (2023) Acupuncture for protracted opioid abstinence syndrome: study protocol for a systematic review and meta-analysis. BMJ Open 13:6, pages e071864.
Crossref
Crossref
Sarah Kanana Kiburi, Edith Kamaru Kwobah, Saeeda Paruk & Bonginkosi Chiliza. (2023) Feasibility, acceptability and preliminary efficacy of a cognitive behavior therapy text-message intervention among individuals with opioid use disorder in Kenya: a randomized feasibility trial. BMC Digital Health 1:1.
Crossref
Crossref
Sarah Kanana Kiburi, Elizabeth Ngarachu, Andrew Tomita, Saeeda Paruk & Bonginkosi Chiliza. (2023) Digital interventions for opioid use disorder treatment: A systematic review of randomized controlled trials. Journal of Substance Abuse Treatment 144, pages 108926.
Crossref
Crossref
Sarah Kanana Kiburi, Jackline Mwangi & Geoffrey Maina. (2022) Exploring the experiences of clients receiving opioid use disorder treatment at a methadone clinic in Kenya: a qualitative study. Addiction Science & Clinical Practice 17:1.
Crossref
Crossref
Wolfgang Sadee & John C. McKew. (2022) Ligand-Free Signaling of G-Protein-Coupled Receptors: Relevance to μ Opioid Receptors in Analgesia and Addiction. Molecules 27:18, pages 5826.
Crossref
Crossref
Jia‐Jia Zhang, Chang‐Geng Song, Ji‐Min Dai, Ling Li, Xiang‐Min Yang & Zhi‐Nan Chen. (2022) Mechanism of opioid addiction and its intervention therapy: Focusing on the reward circuitry and mu‐opioid receptor. MedComm 3:3.
Crossref
Crossref
Sarah Kanana Kiburi, Saeeda Paruk & Bonginkosi Chiliza. (2022) Mobile phone ownership, digital technology use and acceptability of digital interventions among individuals on opioid use disorder treatment in Kenya. Frontiers in Digital Health 4.
Crossref
Crossref
Bradley V. WattsDaniel J. GottliebNatalie B. RibletJiang GuiBrian Shiner. (2022) Association of Medication Treatment for Opioid Use Disorder With Suicide Mortality. American Journal of Psychiatry 179:4, pages 298-304.
Crossref
Crossref
Jamie K. Manganti, Khadejah F. Mahmoud, Ann M. Mitchell & Hayley D. Germack. (2022) Learning From the Lived Experiences of People With Opioid Use Disorder. Journal of Addictions Nursing 33:2, pages 103-113.
Crossref
Crossref
Norsyifa Harun, Nur Azzalia Kamaruzaman, Zarif Mohamed Sofian & Zurina Hassan. (2022) Mini review: Potential therapeutic values of mitragynine as an opioid substitution therapy. Neuroscience Letters 773, pages 136500.
Crossref
Crossref
Joanna M. Streck, Susan Regan, Sara Kalkhoran, Kelly M. Kalagher, Benjamin Bearnot, Priya S. Gupta, Sarah Wakeman & Nancy A. Rigotti. (2022) Perceptions of E-cigarettes among adults in treatment for opioid use disorder. Drug and Alcohol Dependence Reports 2, pages 100023.
Crossref
Crossref
Elizabeth Wambui Ngarachu, Sarah Kanana Kiburi, Frederick R. Owiti & Rachel Kangethe. (2022) The prevalence and pattern of cannabis use among patients attending a methadone treatment clinic in Nairobi, Kenya. Substance Abuse Treatment, Prevention, and Policy 17:1.
Crossref
Crossref
Yen-Jung Chen, Ju-Ting Lu, Chun-Wei Huang, Wei-Hsin Wu, Kuei-Fang Lee, Hsin-Tzu Liu & Lawrence Shih-Hsin Wu. (2021) Pharmacogenetic study of methadone treatment for heroin addiction: associations between drug-metabolizing gene polymorphisms and treatment efficacy. Pharmacogenetics and Genomics 32:1, pages 31-38.
Crossref
Crossref
Elizabeth C. Saunders, Alan J. Budney, Patricia Cavazos-Rehg, Emily Scherer & Lisa A. Marsch. (2021) Comparing the feasibility of four web-based recruitment strategies to evaluate the treatment preferences of rural and urban adults who misuse non-prescribed opioids. Preventive Medicine 152, pages 106783.
Crossref
Crossref
Muhammad Zaeem Ahsan, Meng-Jing Zhao, Rana Muhammad Shoaib, Yan Zhang & Yong-Xiang Wang. (2021) Comparative study of dezocine, pentazocine and tapentadol on antinociception and physical dependence. Life Sciences 285, pages 119996.
Crossref
Crossref
Kristin Klemmetsby Solli, Arild Opheim, Zill‐e‐Huma Latif, Peter Krajci, Jūratė Šaltytė Benth, Nikolaj Kunoe & Lars Tanum. (2021) Adapting treatment length to opioid‐dependent individuals’ needs and preferences: a 2‐year follow‐up to a 1‐year study of extended‐release naltrexone. Addiction 116:8, pages 2084-2093.
Crossref
Crossref
Tao Wang, Xun Zhu, Hyun Yi, Jun Gu, Shue Liu, Sari Izenwasser, Vance P Lemmon, Sabita Roy & Shuanglin Hao. (2021) Viral vector-mediated gene therapy for opioid use disorders. Experimental Neurology 341, pages 113710.
Crossref
Crossref
Shane Kaski, Patrick Marshalek, Jeremy Herschler, Sijin Wen & Wanhong Zheng. (2021) Sublingual Buprenorphine/Naloxone and Multi-Modal Management for High-Risk Chronic Pain Patients. Journal of Clinical Medicine 10:5, pages 973.
Crossref
Crossref
Jordan M. Hyatt & Philipp P. Lobmaier. (2020) Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participation. Health & Justice 8:1.
Crossref
Crossref
Christine LaGrotta. (2020) Treatment of Opioid Use Disorder in the Elderly. Current Treatment Options in Psychiatry 7:4, pages 531-543.
Crossref
Crossref
Joseph V. PergolizziJrJr, Robert B. Raffa & Melanie H. Rosenblatt. (2020) Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management. Journal of Clinical Pharmacy and Therapeutics 45:5, pages 892-903.
Crossref
Crossref
Ya-Ping Li, Ying Yang, Mu-Qi Wang, Xin Zhang, Wen-Jun Wang, Mei Li, Feng-Ping Wu & Shuang-Suo Dang. (2020) Facial and bilateral lower extremity edema due to drug-drug interactions in a patient with hepatitis C virus infection and benign prostate hypertrophy: A case report. World Journal of Clinical Cases 8:15, pages 3372-3376.
Crossref
Crossref
Molly Minkiewicz, Paul W. Czoty, Bruce E. Blough & Michael A. Nader. (2020) Evaluation of the Reinforcing Strength of Phendimetrazine Using a Progressive-Ratio Schedule of Reinforcement in Rhesus Monkeys. Journal of Pharmacology and Experimental Therapeutics 374:1, pages 1-5.
Crossref
Crossref
Saeed Kianbakht, Reza Hajiaghaee & Shahin Akhondzadeh. (2019)
Efficacy and safety of
Sophora alopecuroides
var.
alopecuroides
seed extract for opioid detoxification: A randomized, double‐blind, and placebo‐controlled clinical trial
. Phytotherapy Research 34:5, pages 1108-1113.
Crossref
Crossref
Alexis S. Hammond, Kelly E. Dunn & Eric C. Strain. (2020) Drug Legalization and Decriminalization Beliefs Among Substance-using and Nonusing Individuals. Journal of Addiction Medicine 14:1, pages 56-62.
Crossref
Crossref
Frances R. Levin, John J. Mariani, Martina Pavlicova, C. Jean Choi, Amy L. Mahony, Daniel J. Brooks, Adam Bisaga, Elias Dakwar, Kenneth M. Carpenter, Nasir Naqvi, Edward V. Nunes & Kyle Kampman. (2020) Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users. Drug and Alcohol Dependence 206, pages 107700.
Crossref
Crossref
Bhavani Kashyap, Leah R. Hanson & William H. Frey II. (2020) Intranasal Insulin: a Treatment Strategy for Addiction. Neurotherapeutics 17:1, pages 105-115.
Crossref
Crossref
Silvia Franchi, Giorgia Moschetti, Giada Amodeo & Paola Sacerdote. (2019) Do All Opioid Drugs Share the Same Immunomodulatory Properties? A Review From Animal and Human Studies. Frontiers in Immunology 10.
Crossref
Crossref
Li-wan Zhang, Qing Guo, Rui Fang, Li Lin, Bin-hua Ye, Kai-lin Zheng, Min Lin, Zhao-yang Yang, Ji-qian Fang & Can-dong Li. (2019) Traditional Chinese Medicine-Guided Dietary Intervention for Male Youth Undergoing Drug Detoxification: A Randomized Controlled Trial. Evidence-Based Complementary and Alternative Medicine 2019, pages 1-12.
Crossref
Crossref
Jun Ma, Yan-Ping Bao, Ru-Jia Wang, Meng-Fan Su, Mo-Xuan Liu, Jin-Qiao Li, Louisa Degenhardt, Michael Farrell, Frederic C. Blow, Mark Ilgen, Jie Shi & Lin Lu. (2018) Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Molecular Psychiatry 24:12, pages 1868-1883.
Crossref
Crossref
Allison M. Elias, Marc J. Pepin & Jamie N. Brown. (2019) Adjunctive memantine for opioid use disorder treatment: A systematic review. Journal of Substance Abuse Treatment 107, pages 38-43.
Crossref
Crossref
R. Ross MacLean, Jessica L. Armstrong & Mehmet Sofuoglu. (2019) Stress and opioid use disorder: A systematic review. Addictive Behaviors 98, pages 106010.
Crossref
Crossref
Tyler S. Oesterle, Nuria J. Thusius, Teresa A. Rummans & Mark S. Gold. (2019) Medication-Assisted Treatment for Opioid-Use Disorder. Mayo Clinic Proceedings 94:10, pages 2072-2086.
Crossref
Crossref
Christopher A. Blackwood, Michael Leary, Aaron Salisbury, Michael T. McCoy & Jean Lud Cadet. (2019) Escalated Oxycodone Self-Administration Causes Differential Striatal mRNA Expression of FGFs and IEGs Following Abstinence-Associated Incubation of Oxycodone Craving. Neuroscience 415, pages 173-183.
Crossref
Crossref
Mehmet Sofuoglu, Elise E. DeVito & Kathleen M. Carroll. (2018) Pharmacological and Behavioral Treatment of Opioid Use Disorder. Psychiatric Research and Clinical Practice 1:1, pages 4-15.
Crossref
Crossref
Aliza T. Ehrlich, Meriem Semache, Florence Gross, Dillon F. Da Fonte, Leonie Runtz, Christine Colley, Amina Mezni, Christian Le Gouill, Viktoriya Lukasheva, Mireille Hogue, Emmanuel Darcq, Michel Bouvier & Brigitte L. Kieffer. (2019) Biased Signaling of the Mu Opioid Receptor Revealed in Native Neurons. iScience 14, pages 47-57.
Crossref
Crossref
Hestia Moningka, Sarah Lichenstein & Sarah W. Yip. (2019) Current Understanding of the Neurobiology of Opioid Use Disorder: an Overview. Current Behavioral Neuroscience Reports 6:1, pages 1-11.
Crossref
Crossref
Margaret E. Olson, Lisa M. Eubanks & Kim D. Janda. (2018) Chemical Interventions for the Opioid Crisis: Key Advances and Remaining Challenges. Journal of the American Chemical Society 141:5, pages 1798-1806.
Crossref
Crossref
Thomas R. Kosten & Louis E. Baxter. (2019) Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment. The American Journal on Addictions 28:2, pages 55-62.
Crossref
Crossref
Tomislav Majić, Stefan Gutwinski, Christian A. Müller, Nikola Schoofs & Andreas Heinz. 2019. Suchtmedizin. Suchtmedizin
81
90
.
Michael H. Baumann, Theresa A. Kopajtic & Bertha K. Madras. (2018) Pharmacological Research as a Key Component in Mitigating the Opioid Overdose Crisis. Trends in Pharmacological Sciences 39:12, pages 995-998.
Crossref
Crossref
R. Ross MacLean, Mehmet Sofuoglu, Emily Brede, Cendrine Robinson & Andrew J. Waters. (2018) Attentional bias in opioid users: A systematic review and meta-analysis. Drug and Alcohol Dependence 191, pages 270-278.
Crossref
Crossref
Emmanuel Darcq & Brigitte Lina Kieffer. (2018) Opioid receptors: drivers to addiction?. Nature Reviews Neuroscience 19:8, pages 499-514.
Crossref
Crossref
Frances R. Levin, C. Jean Choi, Martina Pavlicova, John J. Mariani, Amy Mahony, Daniel J. Brooks, Edward V. Nunes & John Grabowski. (2018) How treatment improvement in ADHD and cocaine dependence are related to one another: A secondary analysis. Drug and Alcohol Dependence 188, pages 135-140.
Crossref
Crossref
Charitha Gowda & Vincent Lo ReIIIIII. (2018) Strategies for the Elimination of Hepatitis C Virus Infection as a Public Health Threat in the United States. Current Hepatology Reports 17:2, pages 111-120.
Crossref
Crossref
David J. ClarkMark A. Schumacher. (2017) America’s Opioid Epidemic: Supply and Demand Considerations. Anesthesia & Analgesia 125:5, pages 1667-1674.
Crossref
Crossref
Phuong Chi Pham, Kathy Khaing, Theodore M. Sievers, Phuong Mai Pham, Jeffrey M. Miller, Son V. Pham, Phuong Anh Pham & Phuong Thu Pham. (2017) 2017 update on pain management in patients with chronic kidney disease. Clinical Kidney Journal 10:5, pages 688-697.
Crossref
Crossref
Tran H. Tran, Brooke L. Griffin, Rebecca H. Stone, Kathleen M. Vest & Timothy J. Todd. (2017) Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37:7, pages 824-839.
Crossref
Crossref